Congratulations to the 2021 Research Grant winners!

2021Rgwinners

The Hague, 2 June 2021 –EHA congratulates nine talented researchers in hematology on their receipt of the EHA Research Grants 2021 after a rigorous selection process. They join a network of over 110 distinguished researchers who have received EHA Research Funding in the past.

EHA Research Grants support talented early career researchers in advancing their career towards becoming leaders of research groups. These grants are intended for basic and translational lab-based research in hematology. Novel and relevant translational parts of a clinical trial can also be funded in compelling circumstances.

EHA continues to support hematology researchers during the COVID-19 pandemic. Recognising the unprecedented challenging research environment characterised by an acute shortage of hematology research funding due to the ongoing pandemic, EHA increased the number of grants in 2021 from six to nine. In addition, the Junior Research Grant has been expanded to €150.000 for 3 years. The 2021 Awardees are in institutes in Italy, the Netherlands, Spain, Sweden, and the United Kingdom.

“It was the blend of both clinical and laboratory work that attracted many of us to hematology and we know that advances in treatment for our patients come from fuller understanding of the pathophysiology of these diseases. Therefore, almost nothing is more important to us at EHA than ensuring the advancement of the next generation of clinicians and scientists in our field. The early steps of a career in research are often the most difficult ones and it is for this reason that we have invested in mentoring programs for our young scientists and clinician scientists, and we are delighted to have increased our grant funding to be able to make a larger contribution towards supporting early career development. I am therefore delighted to be able to congratulate these award winners for their successful application and be able to help their careers in steps towards independence.  We fully expect these very talented individuals to go on to become leaders in their field and also to present their work at future EHA congresses.’’ says EHA President John Gribben, MD DSc FRCP FRCPath FMedSci.

Photo

Name

Category

Project Title

Institute

Country

 

Antonella Fidanza

Advanced Research Grant

The Role of Mechanosignaling in the Embryonic Development of the Human Hematopoietic Tissue

University of Edinburgh

United Kingdom

 

Antonella Nai

Advanced Research Grant

Unravelling the Mechanisms of Erythropoiesis Regulation by TFR2 and its Therapeutic Targeting

Ospedale San Raffaele

Italy

 

Christian Di Buduo

Advanced Research Grant

A New Approach to Understanding the Pathogenesis of Myeloproliferative Neoplasms by Shaping the Endoplasmic Reticulum/Mitochondria Calcium Toolkit Dynamic in Megakaryopoiesis

University of Pavia

Italy

 

Ana Rio-Machin

Junior Research Grant

Uncovering the Molecular Mechanisms and Therapeutic Vulnerabilities of T(6;9)-Driven Acute Myeloid Leukaemia

Barts Cancer Institute, Queen Mary University of London

United Kingdom

 

Cecile Lopez

Junior Research Grant

Gene Regulatory Complexes and Networks Regulated by the ERG Oncogene

University of Cambridge

United Kingdom

 

Els Mansell

Junior Research Grant

Uncovering and Exploiting the Metabolic Basis for HSC Fate Availability

Lund University

Sweden

 

Ferran Nadeu

Junior Research Grant

Tracking the Origin of Chronic Lymphocytic Leukemia Progression and Transformation Through its Genomic and Transcriptomic Footprints

Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)

Spain

 

Giulio Cavalli

Physician Scientists’ Research Grant

Dissecting Paracrine Mechanisms in the Pathogenesis and Treatment of Erdheim-Chester Disease

Ospedale San Raffaelle S.R.L.

Italy

 

Mirjam Belderbos

Physician Scientists’ Research Grant

Peripheral Blood or Bone Marrow Stem Cells? Population Dynamics of Blood in Human Hematopoietic Stem Cell Transplantation Recipients

Princess Máxima Center for Pediatric Oncology

the Netherlands

Hematology is an exciting, fast-paced medical field in the front-line of an ever-changing world. The speed of change in clinical, molecular, and technological innovations confront hematologists with the need to quickly adapt to new techniques and therapies. The Topics-in-Focus program was launched by EHA to support hematologists in this rapidly developing scenario, aiming to raise awareness, provide education, further research, and build a network of experts in specific fast-growing areas. In line with this, EHA is spotlighting research in Immunotherapy and Hemoglobinopathies. In 2021, EHA awarded two Topics-in-Focus grants meant for quality basic or translational research projects. The talented recipients of these grants are from institutes in Greece and Belgium.

Photo

Name

Category

Project Title

Institute

Country

 

Nikoleta Psatha

Topic-in-Focus Advanced Research Grant (Hemoglobinopathies)

Development of New Generation, Erythroid Specific Gene Therapy Vectors for β-Hemoglobinopathies

George Papanikolaou Hospital

Greece

 

Sébastien Anguille

Topic-in-Focus Physician Scientists’ Research Grant (Immunotherapy)

Antigen-specific Non-signaling CARs as Hemato-Oncological Remedy (ANCHOR)

University of Antwerp / Antwerp University Hospital

Belgium

The next call for applications for Research Grants will open in the fall of 2021. Information about EHA grants program can be found at https://ehaweb.org/research/grants/  

The European Hematology Association (EHA) promotes excellence in patient care, research, and education in hematology. EHA envisions a world without blood disorders by connecting hematologists worldwide, supporting their career development and research, harmonizing hematology education, and advocating the interests of hematology and hematologists in the European arena.

 

Last Updated on Wednesday 02 June 2021.